Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3 Sell
2
-583
-100% -$976 ﹤0.01% 10368
2025
Q4
$959 Buy
585
+583
+29,150% +$1.64K ﹤0.01% 9751
2025
Q3
$7 Hold
2
﹤0.01% 10209
2025
Q2
$6 Hold
2
﹤0.01% 10166
2025
Q1
$5 Hold
2
﹤0.01% 10140
2024
Q4
$5 Sell
2
-13,399
-100% -$32K ﹤0.01% 9830
2024
Q3
$32.1K Buy
13,401
+11,721
+698% +$37.5K ﹤0.01% 7095
2024
Q2
$6.84K Sell
1,680
-616
-27% -$3.04K ﹤0.01% 7883
2024
Q1
$13.1K Buy
+2,296
New +$14.5K ﹤0.01% 7119
2023
Q4
Sell
-6
Closed -$97 9246
2023
Q3
$97 Buy
6
+4
+200% +$75 ﹤0.01% 8891
2023
Q2
$37 Sell
2
-129
-98% -$2.45K ﹤0.01% 8634
2023
Q1
$2.86K Sell
131
-277
-68% -$5.55K ﹤0.01% 8425
2022
Q4
$6.33K Buy
408
+406
+20,300% +$10.3K ﹤0.01% 9046
2022
Q3
$0 Buy
+2
New +$105 ﹤0.01% 10276

Other funds holding AIMD

UBS Group's AIMD Position: Q1 2026 in Review

UBS Group reduced its Ainos (AIMD) stake by 100% in Q1 2026, selling an estimated $976 and leaving 2 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #10368.

UBS Group first reported a position in AIMD in Q3 2022 and has held it in 14 quarters since. The position peaked at $32.1K in Q3 2024. 12 funds tracked by Wall St. Rank hold AIMD as of Q1 2026.

  • UBS Group held 2 shares of Ainos worth $3 as of Q1 2026.
  • UBS Group sold 583 Ainos shares in Q1 2026, an estimated $976.
  • Ainos made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10368 holding.
  • UBS Group first reported a position in Ainos in Q3 2022 and has held it in 14 quarters since.
  • UBS Group's Ainos position peaked at $32.1K in Q3 2024.
  • 12 funds tracked by Wall St. Rank held Ainos as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.